Literature DB >> 27600364

Sensitive and Specific Preclinical Identification of Alzheimer Disease: A Key to Novel Intervention Development.

Barton W Palmer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27600364      PMCID： PMC6386150          DOI： 10.1016/j.jagp.2016.07.010

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN： 1064-7481            Impact factor:   4.105


× No keyword cloud information.
  5 in total

1.  Edouard Claparède and the auditory verbal learning test.

Authors:  C Boake
Journal:  J Clin Exp Neuropsychol       Date:  2000-04       Impact factor: 2.475

Review 2.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

3.  Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; Mark F Desrosiers; William R Markesbery
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

Review 4.  A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease.

Authors:  Kevin R Peters; B Lynn Beattie; Howard H Feldman; Judy Illes
Journal:  Prog Neurobiol       Date:  2013-01-21       Impact factor: 11.685

Review 5.  Disease-modifying therapies for Alzheimer disease: challenges to early intervention.

Authors:  Jeffrey L Cummings; Rachelle Doody; Christopher Clark
Journal:  Neurology       Date:  2007-10-16       Impact factor: 9.910
  5 in total
  1 in total

1.  A Three-Factor Structure of Cognitive Functioning Among Unimpaired Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.

Authors:  Edmarie Guzmán-Vélez; Sehily Jaimes; Daniel C Aguirre-Acevedo; Daniel J Norton; Kathryn V Papp; Rebecca Amariglio; Dorene Rentz; Ana Baena; Eliana Henao; Victoria Tirado; Claudia Muñoz; Margarita Giraldo; Reisa A Sperling; Francisco Lopera; Yakeel T Quiroz
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.